Pandemic Response Sample Collection from Healthy Participants and Participants with Cancer
In response to the global COVID-19 pandemic, iProcess provided crucial support of an initiative aimed at supporting the rapid deployment and expansion of SARS-CoV-2 serological and other immunological testing. The initiative sought to mobilize collaborative efforts to collect blood from SARS-CoV-2 infected and vaccinated individuals to address key immunological questions and advance testing capabilities.
SARS-CoV-2 Sample Collection
During the global COVID-19 pandemic, iProcess was contracted by a major medical device/healthcare company to help prospectively collect SARS-CoV-2 samples to be used as validation materials for their novel test platform.